Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus-Reference-Cited by-同舟云学术

Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus

Published:2021-09-09 Issue: Volume:Publish Ahead of Print Page:
ISSN:2542-5641
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Huang Jing-Jun,Cai Ming-Yue,Huang Wen-Sou,Guo Yong-Jian,Zhou Jing-Wen,Liang Li-Cong,Lin Li-Teng,Zhou Zhi-Mei,Lian Hui,He Ming-Ji,Zhu Kang-Shun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference5 articles.

1. Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib – a retrospective controlled study;Zhu;Radiology,2014

2. Safety and efficacy of irradiation stent placement for malignant portal vein thrombus combined with transarterial chemoembolization for hepatocellular carcinoma: a single-center experience;Lu;J Vasc Interv Radiol,2017

3. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus;Pan;Clin Radiol,2014

4. CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma;Zhang;Chin Med J,2008

5. 125I irradiation stent for hepatocellular carcinoma with main portal vein tumor thrombosis: a systematic review;Zhang;Cardiovasc Intervent Radiol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of radioactive iodine-125 microparticles in hepatocellular carcinoma with portal vein embolus;World Journal of Gastrointestinal Surgery;2024-07-27

2. Efficacy and safety of transarterial chemoembolization combined with lenvatinib and PD-1 inhibitor in the treatment of advanced hepatocellular carcinoma: A meta-analysis;Pharmacology & Therapeutics;2024-05

3. Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study;Cancer Imaging;2023-09-25

4. Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study;Frontiers in Immunology;2023-07-31

5. Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis;Frontiers in Oncology;2022-09-13